First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study-Reference-Cited by-同舟云学术

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study

Published:2017-12-04 Issue:67 Volume:8 Page:111795-111806
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tomasello Gianluca¹,Valeri Nicola²³,Ghidini Michele¹,Smyth Elizabeth C.³,Liguigli Wanda¹,Toppo Laura¹,Mattioli Rodolfo⁴,Curti Alessandra¹,Hahne Jens C.²,Negri Federica M.¹,Panni Stefano¹,Ratti Margherita¹,Lazzarelli Silvia¹,Gerevini Fabiana¹,Colombi Chiara¹,Panni Andrea⁵,Rovatti Massimo⁶,Treccani Leonardo⁷,Martinotti Mario⁶,Passalacqua Rodolfo¹

Affiliation:

1. Oncology Division, ASST Ospedale di Cremona, Cremona, Italy

2. Division of Molecular Pathology, The Institute for Cancer Research, Sutton, London, UK

3. Department of Medicine, The Royal Marsden Hospital, Sutton, London, UK

4. Oncology Division, Ospedali Riuniti Marche Nord, Fano, Italy

5. Pathology Division, ASST Ospedale di Cremona, Cremona, Italy

6. Surgery Division, ASST Ospedale di Cremona, Cremona, Italy

7. Radiology Division, ASST Ospedale di Cremona, Cremona, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of breast cancer subtypes to improve benefits of intensive dose‑dense chemotherapy: A systematic meta‑analysis;Oncology Letters;2023-11-07

2. EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers;Gut;2020-11-16

3. Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer;Anti-Cancer Drugs;2020-03

4. Co-operative groups in the development of chemotherapy for gastric cancer;Japanese Journal of Clinical Oncology;2018-12-01

5. New therapeutic options opened by the molecular classification of gastric cancer;World Journal of Gastroenterology;2018-05-14